Artelo Biosciences Adopts Solana Treasury Strategy with $9.5M Investment

Discover how Artelo Biosciences becomes the first publicly-traded pharma company to adopt Solana (SOL) as a core reserve asset with a $9.5M private placement.

August 4, 2025